Incidence, Clinical Features, Management, and Prevention of Herpes Zoster in Patients Receiving Antitumor Necrosis Factor Therapy: A Clinical Review

Tumor necrosis factor (TNF) inhibitors have been used as an excellent therapeutic option in a variety of chronic inflammatory conditions. However, a recognized significant adverse effect of TNF inhibitor therapy is the increased risk of infections. The influence of TNF inhibitors on the course of co...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Byung-Soo, Maverakis, Emanual, Alexanian, Clarie, Wang, Jenny Z., Raychaudhuri, Siba P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238506/
https://www.ncbi.nlm.nih.gov/pubmed/32238066
http://dx.doi.org/10.1177/1203475420914622
_version_ 1783536544132366336
author Kim, Byung-Soo
Maverakis, Emanual
Alexanian, Clarie
Wang, Jenny Z.
Raychaudhuri, Siba P.
author_facet Kim, Byung-Soo
Maverakis, Emanual
Alexanian, Clarie
Wang, Jenny Z.
Raychaudhuri, Siba P.
author_sort Kim, Byung-Soo
collection PubMed
description Tumor necrosis factor (TNF) inhibitors have been used as an excellent therapeutic option in a variety of chronic inflammatory conditions. However, a recognized significant adverse effect of TNF inhibitor therapy is the increased risk of infections. The influence of TNF inhibitors on the course of coexisting or newly developed viral infections has not been extensively investigated. Therefore, we reviewed the recent publications to highlight the incidence, clinical features, management, and prevention of herpes zoster in patients who are receiving TNF inhibitors.
format Online
Article
Text
id pubmed-7238506
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-72385062020-06-15 Incidence, Clinical Features, Management, and Prevention of Herpes Zoster in Patients Receiving Antitumor Necrosis Factor Therapy: A Clinical Review Kim, Byung-Soo Maverakis, Emanual Alexanian, Clarie Wang, Jenny Z. Raychaudhuri, Siba P. J Cutan Med Surg Review Articles Tumor necrosis factor (TNF) inhibitors have been used as an excellent therapeutic option in a variety of chronic inflammatory conditions. However, a recognized significant adverse effect of TNF inhibitor therapy is the increased risk of infections. The influence of TNF inhibitors on the course of coexisting or newly developed viral infections has not been extensively investigated. Therefore, we reviewed the recent publications to highlight the incidence, clinical features, management, and prevention of herpes zoster in patients who are receiving TNF inhibitors. SAGE Publications 2020-04-02 2020-05 /pmc/articles/PMC7238506/ /pubmed/32238066 http://dx.doi.org/10.1177/1203475420914622 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc-nd/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NoDerivs 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/) which permits any use, reproduction and distribution of the work as published without adaptation or alteration, provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Review Articles
Kim, Byung-Soo
Maverakis, Emanual
Alexanian, Clarie
Wang, Jenny Z.
Raychaudhuri, Siba P.
Incidence, Clinical Features, Management, and Prevention of Herpes Zoster in Patients Receiving Antitumor Necrosis Factor Therapy: A Clinical Review
title Incidence, Clinical Features, Management, and Prevention of Herpes Zoster in Patients Receiving Antitumor Necrosis Factor Therapy: A Clinical Review
title_full Incidence, Clinical Features, Management, and Prevention of Herpes Zoster in Patients Receiving Antitumor Necrosis Factor Therapy: A Clinical Review
title_fullStr Incidence, Clinical Features, Management, and Prevention of Herpes Zoster in Patients Receiving Antitumor Necrosis Factor Therapy: A Clinical Review
title_full_unstemmed Incidence, Clinical Features, Management, and Prevention of Herpes Zoster in Patients Receiving Antitumor Necrosis Factor Therapy: A Clinical Review
title_short Incidence, Clinical Features, Management, and Prevention of Herpes Zoster in Patients Receiving Antitumor Necrosis Factor Therapy: A Clinical Review
title_sort incidence, clinical features, management, and prevention of herpes zoster in patients receiving antitumor necrosis factor therapy: a clinical review
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238506/
https://www.ncbi.nlm.nih.gov/pubmed/32238066
http://dx.doi.org/10.1177/1203475420914622
work_keys_str_mv AT kimbyungsoo incidenceclinicalfeaturesmanagementandpreventionofherpeszosterinpatientsreceivingantitumornecrosisfactortherapyaclinicalreview
AT maverakisemanual incidenceclinicalfeaturesmanagementandpreventionofherpeszosterinpatientsreceivingantitumornecrosisfactortherapyaclinicalreview
AT alexanianclarie incidenceclinicalfeaturesmanagementandpreventionofherpeszosterinpatientsreceivingantitumornecrosisfactortherapyaclinicalreview
AT wangjennyz incidenceclinicalfeaturesmanagementandpreventionofherpeszosterinpatientsreceivingantitumornecrosisfactortherapyaclinicalreview
AT raychaudhurisibap incidenceclinicalfeaturesmanagementandpreventionofherpeszosterinpatientsreceivingantitumornecrosisfactortherapyaclinicalreview

Ejemplares similares